{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T11:51:11Z","timestamp":1790769071539,"version":"4.1.0"},"reference-count":63,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,9,22]],"date-time":"2020-09-22T00:00:00Z","timestamp":1600732800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell Dev. Biol."],"DOI":"10.3389\/fcell.2020.576592","type":"journal-article","created":{"date-parts":[[2020,9,22]],"date-time":"2020-09-22T01:07:13Z","timestamp":1600736833000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":40,"title":["Mitochondrial and Redox Modifications in Huntington Disease Induced Pluripotent Stem Cells Rescued by CRISPR\/Cas9 CAGs Targeting"],"prefix":"10.3389","volume":"8","author":[{"given":"Carla","family":"Lopes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra I.","family":"Anjo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Manadas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"Onofre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu\u00eds P.","family":"de Almeida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George Q.","family":"Daley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thorsten M.","family":"Schlaeger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Cristina Carvalho","family":"Rego","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,9,22]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1371\/currents.hd.0242d2e7ad72225efa72f6964589369a","article-title":"Polyglutamine disease modeling: epitope based screen for homologous recombination using CRISPR\/Cas9 system.","volume":"6","author":"An","year":"2014","journal-title":"PLoS Curr."},{"key":"B2","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.stem.2012.04.026","article-title":"Genetic correction of Huntington\u2019s disease phenotypes in induced pluripotent stem cells [Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov\u2019t].","volume":"11","author":"An","year":"2012","journal-title":"Cell. Stem Cell"},{"key":"B3","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1242\/jcs.072272","article-title":"A reduction in ATP demand and mitochondrial activity with neural differentiation of human embryonic stem cells.","volume":"124","author":"Birket","year":"2011","journal-title":"J. Cell Sci."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1016\/j.ymthe.2017.05.015","article-title":"Using CRISPR-Cas9 to generate gene-corrected autologous iPSCs for the treatment of inherited retinal degeneration.","volume":"25","author":"Burnight","year":"2017","journal-title":"Mol. Ther."},{"key":"B5","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.nbd.2011.12.042","article-title":"The first reported generation of several induced pluripotent stem cell lines from homozygous and heterozygous Huntington\u2019s disease patients demonstrates mutation related enhanced lysosomal activity [Research Support, Non-U.S. Gov\u2019t].","volume":"46","author":"Camnasio","year":"2012","journal-title":"Neurobiol. Dis."},{"key":"B6","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1042\/BJ20111495","article-title":"Quantitative proteomic analysis of induced pluripotent stem cells derived from a human Huntington\u2019s disease patient [Research Support, Non-U.S. Gov\u2019t].","volume":"446","author":"Chae","year":"2012","journal-title":"Biochem. J."},{"key":"B7","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1038\/nbt.1529","article-title":"Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling [Research Support, N.I.H., ExtramuralResearch Support, Non-U. S. Gov\u2019t].","volume":"27","author":"Chambers","year":"2009","journal-title":"Nat. Biotechnol."},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1186\/s13287-015-0264-1","article-title":"Modeling autosomal dominant optic atrophy using induced pluripotent stem cells and identifying potential therapeutic targets.","volume":"7","author":"Chen","year":"2016","journal-title":"Stem Cell Res. Ther."},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2020.104741","article-title":"Mitochondrial fission in Huntington\u2019s disease mouse striatum disrupts ER-mitochondria contacts leading to disturbances in Ca.","volume":"136","author":"Cherubini","year":"2020","journal-title":"Neurobiol. Dis."},{"key":"B10","doi-asserted-by":"publisher","first-page":"2145","DOI":"10.1016\/j.bbadis.2015.06.025","article-title":"Cdk5-mediated mitochondrial fission: A key player in dopaminergic toxicity in Huntington\u2019s disease.","volume":"1852","author":"Cherubini","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1016\/j.bbrc.2006.08.020","article-title":"Dynamic changes in mitochondrial biogenesis and antioxidant enzymes during the spontaneous differentiation of human embryonic stem cells [Research Support, Non-U.S. Gov\u2019t].","volume":"348","author":"Cho","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2018.00075","article-title":"Precise Excision of the CAG Tract from the Huntingtin Gene by Cas9 Nickases.","volume":"12","author":"Dabrowska","year":"2018","journal-title":"Front. Neurosci."},{"key":"B13","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1007\/s12015-013-9441-8","article-title":"Human pluripotent stem cell differentiation into authentic striatal projection neurons [Research Support, Non-U.S. Gov\u2019t].","volume":"9","author":"Delli Carri","year":"2013","journal-title":"Stem Cell Rev."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1016\/j.bbabio.2008.12.012","article-title":"Regulation of plasma membrane calcium fluxes by mitochondria [Research Support, Non-U.S. Gov\u2019t Review].","volume":"1787","author":"Demaurex","year":"2009","journal-title":"Biochim. Biophys. Acta"},{"key":"B15","doi-asserted-by":"publisher","first-page":"4025","DOI":"10.1242\/jcs.016972","article-title":"Mitochondrial DNA replication during differentiation of murine embryonic stem cells [Research Support, Non-U.S. Gov\u2019t].","volume":"120","author":"Facucho-Oliveira","year":"2007","journal-title":"J. Cell Sci."},{"key":"B16","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.expneurol.2011.05.024","article-title":"Bioenergetic dysfunction in Huntington\u2019s disease human cybrids [Research Support. Non-U.S. Gov\u2019t].","volume":"231","author":"Ferreira","year":"2011","journal-title":"Exp. Neurol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"8139","DOI":"10.1096\/fj.201902277RR","article-title":"Expression of mutant exon 1 huntingtin fragments in human neural stem cells and neurons causes inclusion formation and mitochondrial dysfunction.","volume":"34","author":"Ghosh","year":"2020","journal-title":"FASEB J."},{"key":"B18","doi-asserted-by":"publisher","first-page":"2803","DOI":"10.1111\/j.1460-9568.2008.06310.x","article-title":"Mechanisms of neurodegeneration in Huntington\u2019s disease [Research Support, Non-U.S. Gov\u2019t Review].","volume":"27","author":"Gil","year":"2008","journal-title":"Eur. J. Neurosci."},{"key":"B19","doi-asserted-by":"publisher","first-page":"5371","DOI":"10.1172\/JCI70911","article-title":"Inhibition of mitochondrial fragmentation diminishes Huntington\u2019s disease-associated neurodegeneration.","volume":"123","author":"Guo","year":"2013","journal-title":"J. Clin. Invest."},{"key":"B20","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1007\/s12035-019-01734-2","article-title":"Energy metabolism and mitochondrial superoxide anion production in pre-symptomatic striatal neurons derived from human-induced pluripotent stem cells expressing mutant huntingtin.","volume":"57","author":"Hamilton","year":"2020","journal-title":"Mol. Neurobiol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.stem.2012.04.027","article-title":"Induced pluripotent stem cells from patients with Huntington\u2019s disease show CAG-repeat-expansion-associated phenotypes [Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov\u2019t].","volume":"11","year":"2012","journal-title":"Cell. Stem Cell"},{"key":"B22","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1038\/nn.4532","article-title":"Developmental alterations in Huntington\u2019s disease neural cells and pharmacological rescue in cells and mice.","volume":"20","year":"2017","journal-title":"Nat. Neurosci."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1093\/hmg\/ddy430","article-title":"Bioenergetic deficits in Huntington\u2019s disease iPSC-derived neural cells and rescue with glycolytic metabolites.","volume":"29","year":"2020","journal-title":"Hum. Mol. Genet."},{"key":"B24","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.expneurol.2016.10.017","article-title":"Mitochondrial cristae remodelling is associated with disrupted OPA1 oligomerisation in the Huntington\u2019s disease R6\/2 fragment model.","volume":"288","author":"Hering","year":"2017","journal-title":"Exp. Neurol."},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0126860","article-title":"Three huntington\u2019s disease specific mutation-carrying human embryonic stem cell lines have stable number of cag repeats upon in vitro differentiation into cardiomyocytes","volume":"10","author":"Jacquet","year":"2015","journal-title":"PLoS One"},{"key":"B26","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.yjmcc.2018.12.004","article-title":"Drp1\/Fis1-mediated mitochondrial fragmentation leads to lysosomal dysfunction in cardiac models of Huntington\u2019s disease.","volume":"127","author":"Joshi","year":"2019","journal-title":"J. Mol. Cell Cardiol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12015-011-9318-7","article-title":"The effects of nuclear reprogramming on mitochondrial DNA replication.","volume":"9","author":"Kelly","year":"2013","journal-title":"Stem Cell Rev."},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3390\/ijms18040754","article-title":"CRISPR-Cas9 Mediated Gene-Silencing of the Mutant Huntingtin Gene in an In Vitro Model of Huntington\u2019s Disease.","volume":"18","author":"Kolli","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"B29","doi-asserted-by":"publisher","first-page":"37223","DOI":"10.1074\/jbc.M103069200","article-title":"Site specificity of four pyruvate dehydrogenase kinase isoenzymes toward the three phosphorylation sites of human pyruvate dehydrogenase.","volume":"276","author":"Korotchkina","year":"2001","journal-title":"J. Biol. Chem."},{"key":"B30","doi-asserted-by":"publisher","first-page":"659.e9","DOI":"10.1016\/j.stem.2016.12.013","article-title":"Human iPSC-derived neural progenitors are an effective drug discovery model for neurological mtDNA disorders.","volume":"20","author":"Lorenz","year":"2017","journal-title":"Cell Stem Cell"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3010523","article-title":"Targeting ATM ameliorates mutant Huntingtin toxicity in cell and animal models of Huntington\u2019s disease.","volume":"6","author":"Lu","year":"2014","journal-title":"Sci. Transl. Med."},{"key":"B32","doi-asserted-by":"publisher","first-page":"3257","DOI":"10.1093\/hmg\/ddv080","article-title":"HD iPSC-derived neural progenitors accumulate in culture and are susceptible to BDNF withdrawal due to glutamate toxicity [Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov\u2019t].","volume":"24","author":"Mattis","year":"2015","journal-title":"Hum. Mol. Genet."},{"key":"B33","doi-asserted-by":"publisher","first-page":"5648","DOI":"10.1021\/pr500649m","article-title":"Proteomics of Huntington\u2019s disease-affected human embryonic stem cells reveals an evolving pathology involving mitochondrial dysfunction and metabolic disturbances.","volume":"13","author":"McQuade","year":"2014","journal-title":"J. Proteome Res."},{"key":"B34","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.ymthe.2016.11.010","article-title":"CRISPR\/Cas9 Editing of the mutant huntingtin allele in vitro and in vivo.","volume":"25","author":"Monteys","year":"2017","journal-title":"Mol. Ther."},{"key":"B35","doi-asserted-by":"publisher","first-page":"2776","DOI":"10.1523\/JNEUROSCI.2006-14.2016","article-title":"Histone deacetylase inhibitors protect against pyruvate dehydrogenase dysfunction in huntington\u2019s disease.","volume":"37","author":"Naia","year":"2017","journal-title":"J. Neurosci."},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-016-0092-5","article-title":"Manifestation of Huntington\u2019s disease pathology in human induced pluripotent stem cell-derived neurons.","volume":"11","author":"Nekrasov","year":"2016","journal-title":"Mol. Neurodegener."},{"key":"B37","doi-asserted-by":"publisher","first-page":"14864","DOI":"10.1074\/jbc.M510916200","article-title":"Simultaneous monitoring of ionophore- and inhibitor-mediated plasma and mitochondrial membrane potential changes in cultured neurons [Research Support, N.I.H., Extramural].","volume":"281","author":"Nicholls","year":"2006","journal-title":"J. Biol. Chem."},{"key":"B38","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1002\/stem.1462","article-title":"Embryonic stem cells neural differentiation qualifies the role of Wnt\/beta-Catenin signals in human telencephalic specification and regionalization [Research Support. Non-U.S. Gov\u2019t].","volume":"31","author":"Nicoleau","year":"2013","journal-title":"Stem Cells"},{"key":"B39","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-e","article-title":"A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington\u2019s disease chromosomes. The huntington\u2019s disease collaborative research group.","volume":"72","year":"1993","journal-title":"Cell"},{"key":"B40","doi-asserted-by":"publisher","first-page":"11174","DOI":"10.1523\/jneurosci.3004-06.2006","article-title":"Mitochondrial-dependent Ca2+ handling in Huntington\u2019s disease striatal cells: effect of histone deacetylase inhibitors.","volume":"26","author":"Oliveira","year":"2006","journal-title":"J Neurosci"},{"key":"B41","doi-asserted-by":"crossref","DOI":"10.1038\/srep28220","article-title":"Fibroblasts of Machado Joseph disease patients reveal autophagy impairment.","volume":"6","author":"Onofre","year":"2016","journal-title":"Sci. Rep."},{"key":"B42","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1038\/nn884","article-title":"Early mitochondrial calcium defects in Huntington\u2019s disease are a direct effect of polyglutamines.","volume":"5","author":"Panov","year":"2002","journal-title":"Nat. Neurosci."},{"key":"B43","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.cell.2008.07.041","article-title":"Disease-specific induced pluripotent stem cells.","volume":"134","author":"Park","year":"2008","journal-title":"Cell"},{"key":"B44","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms9472","article-title":"Mesenchymal stem cells use extracellular vesicles to outsource mitophagy and shuttle microRNAs.","volume":"6","author":"Phinney","year":"2015","journal-title":"Nat. Commun."},{"key":"B45","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1002\/stem.404","article-title":"The senescence-related mitochondrial\/oxidative stress pathway is repressed in human induced pluripotent stem cells [Research Support, Non-U.S. Gov\u2019t].","volume":"28","author":"Prigione","year":"2010","journal-title":"Stem Cells"},{"key":"B46","doi-asserted-by":"publisher","first-page":"E4676","DOI":"10.1073\/pnas.1614943114","article-title":"KEAP1-modifying small molecule reveals muted NRF2 signaling responses in neural stem cells from Huntington\u2019s disease patients.","volume":"114","author":"Quinti","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B47","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.ab.2009.03.040","article-title":"Monitoring phosphorylation of the pyruvate dehydrogenase complex.","volume":"389","author":"Rardin","year":"2009","journal-title":"Anal. Biochem."},{"key":"B48","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.freeradbiomed.2014.06.023","article-title":"Insulin and IGF-1 improve mitochondrial function in a PI-3K\/Akt-dependent manner and reduce mitochondrial generation of reactive oxygen species in Huntington\u2019s disease knock-in striatal cells [Research Support, Non-U.S. Gov\u2019t].","volume":"74","author":"Ribeiro","year":"2014","journal-title":"Free Radic. Biol. Med."},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1186\/1750-1172-5-40","article-title":"Huntington\u2019s disease: a clinical review.","volume":"5","author":"Roos","year":"2010","journal-title":"Orphanet J. Rare Dis."},{"key":"B50","doi-asserted-by":"publisher","first-page":"4566","DOI":"10.1093\/hmg\/ddw286","article-title":"Permanent inactivation of Huntington\u2019s disease mutation by personalized allele-specific CRISPR\/Cas9.","volume":"25","author":"Shin","year":"2016","journal-title":"Hum. Mol. Genet."},{"key":"B51","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1093\/hmg\/ddr024","article-title":"Abnormal mitochondrial dynamics, mitochondrial loss and mutant huntingtin oligomers in Huntington\u2019s disease: implications for selective neuronal damage.","volume":"20","author":"Shirendeb","year":"2011","journal-title":"Hum. Mol. Genet."},{"key":"B52","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1093\/hmg\/ddr475","article-title":"Mutant huntingtin\u2019s interaction with mitochondrial protein Drp1 impairs mitochondrial biogenesis and causes defective axonal transport and synaptic degeneration in Huntington\u2019s disease [Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov\u2019t].","volume":"21","author":"Shirendeb","year":"2012","journal-title":"Hum. Mol. Genet."},{"key":"B53","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1038\/nm.2313","article-title":"Mutant huntingtin binds the mitochondrial fission GTPase dynamin-related protein-1 and increases its enzymatic activity.","volume":"17","author":"Song","year":"2011","journal-title":"Nat. Med."},{"key":"B54","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1002\/ana.410130116","article-title":"Decreased pyruvate dehydrogenase complex activity in Huntington and Alzheimer brain.","volume":"13","author":"Sorbi","year":"1983","journal-title":"Ann. Neurol."},{"key":"B55","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1002\/ajmg.1320200116","article-title":"Red blood cell adenine nucleotides abnormalities in Down syndrome.","volume":"20","author":"Stocchi","year":"1985","journal-title":"Am. J. Med. Genet."},{"key":"B56","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1242\/dmm.019406","article-title":"Huntington disease iPSCs show early molecular changes in intracellular signaling, the expression of oxidative stress proteins and the p53 pathway.","volume":"8","author":"Szlachcic","year":"2015","journal-title":"Dis. Model Mech."},{"key":"B57","doi-asserted-by":"publisher","first-page":"2307","DOI":"10.1056\/NEJMoa1900907","article-title":"Targeting huntingtin expression in patients with Huntington\u2019s disease.","volume":"380","author":"Tabrizi","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0020914","article-title":"Energy metabolism in human pluripotent stem cells and their differentiated counterparts [Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov\u2019t].","volume":"6","author":"Varum","year":"2011","journal-title":"PLoS One"},{"key":"B59","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/j.stemcr.2017.01.022","article-title":"Reversal of phenotypic abnormalities by CRISPR\/Cas9-mediated gene correction in huntington disease patient-derived induced pluripotent stem cells.","volume":"8","author":"Xu","year":"2017","journal-title":"Stem Cell Rep."},{"key":"B60","doi-asserted-by":"publisher","first-page":"2719","DOI":"10.1172\/JCI92087","article-title":"CRISPR\/Cas9-mediated gene editing ameliorates neurotoxicity in mouse model of Huntington\u2019s disease.","volume":"127","author":"Yang","year":"2017","journal-title":"J. Clin. Invest."},{"key":"B61","doi-asserted-by":"publisher","first-page":"4860","DOI":"10.1038\/emboj.2011.401","article-title":"UCP2 regulates energy metabolism and differentiation potential of human pluripotent stem cells [Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov\u2019t].","volume":"30","author":"Zhang","year":"2011","journal-title":"EMBO J."},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1371\/currents.RRN1193","article-title":"Characterization of human Huntington\u2019s disease cell model from induced pluripotent stem cells.","volume":"2","author":"Zhang","year":"2010","journal-title":"PLoS Curr."},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.13374","article-title":"Metabolic reprogramming during neuronal differentiation from aerobic glycolysis to neuronal oxidative phosphorylation.","volume":"5","author":"Zheng","year":"2016","journal-title":"eLife"}],"container-title":["Frontiers in Cell and Developmental Biology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fcell.2020.576592\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,22]],"date-time":"2020-09-22T01:07:17Z","timestamp":1600736837000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fcell.2020.576592\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,22]]},"references-count":63,"alternative-id":["10.3389\/fcell.2020.576592"],"URL":"https:\/\/doi.org\/10.3389\/fcell.2020.576592","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.738920266.793593622","asserted-by":"object"}]},"ISSN":["2296-634X"],"issn-type":[{"value":"2296-634X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,22]]},"article-number":"576592"}}